| Dr Michael John Saffian, MD | |
|
7007 Powers Blvd, Parma, OH 44129-5437 | |
| (440) 350-0832 | |
| (440) 579-0191 |
| Full Name | Dr Michael John Saffian |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 37 Years |
| Location | 7007 Powers Blvd, Parma, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952417073 | NPI | - | NPPES |
| 0736029 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 35.057254 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parma Community General Hospital | Parma, OH | Hospital |
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Primary Care Practices Inc | 3072417534 | 940 |
News Archive
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home, without needing to send a sample to a laboratory for analysis.
SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for point-of-care medicine, today announced the expansion of the SonoAccess™ iPhone® application to include musculoskeletal specialties. SonoAccess is the first iPhone application to provide physicians with a comprehensive multimedia database of ultrasound resource materials.
Patients with recurrent high-grade glioma brain tumors have few effective treatment options and the majority of available therapies do not improve survival. Moffitt Cancer Center will present preliminary results from a phase 1 study testing whether the addition of pembrolizumab to radiation therapy and bevacizumab is safe and can control tumor growth for these patients.
After reviewing thousands of case studies going back 25 years across six countries, generalizable survival data is now available for the first time to estimate how long hip and knee replacements are likely to last.
Geron Corporation today announced the presentation of data from the clinical trial of imetelstat (GRN163L), the company's telomerase inhibitor drug, in combination with paclitaxel and bevacizumab in patients with breast cancer at the 2010 American Society of Clinical Oncology annual meeting in Chicago.
› Verified 5 days ago
| Entity Name | University Primary Care Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home, without needing to send a sample to a laboratory for analysis.
SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for point-of-care medicine, today announced the expansion of the SonoAccess™ iPhone® application to include musculoskeletal specialties. SonoAccess is the first iPhone application to provide physicians with a comprehensive multimedia database of ultrasound resource materials.
Patients with recurrent high-grade glioma brain tumors have few effective treatment options and the majority of available therapies do not improve survival. Moffitt Cancer Center will present preliminary results from a phase 1 study testing whether the addition of pembrolizumab to radiation therapy and bevacizumab is safe and can control tumor growth for these patients.
After reviewing thousands of case studies going back 25 years across six countries, generalizable survival data is now available for the first time to estimate how long hip and knee replacements are likely to last.
Geron Corporation today announced the presentation of data from the clinical trial of imetelstat (GRN163L), the company's telomerase inhibitor drug, in combination with paclitaxel and bevacizumab in patients with breast cancer at the 2010 American Society of Clinical Oncology annual meeting in Chicago.
› Verified 5 days ago
| Entity Name | Anesthesia Associates Pll |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801823182 PECOS PAC ID: 5395648679 Enrollment ID: O20040202000866 |
News Archive
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home, without needing to send a sample to a laboratory for analysis.
SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for point-of-care medicine, today announced the expansion of the SonoAccess™ iPhone® application to include musculoskeletal specialties. SonoAccess is the first iPhone application to provide physicians with a comprehensive multimedia database of ultrasound resource materials.
Patients with recurrent high-grade glioma brain tumors have few effective treatment options and the majority of available therapies do not improve survival. Moffitt Cancer Center will present preliminary results from a phase 1 study testing whether the addition of pembrolizumab to radiation therapy and bevacizumab is safe and can control tumor growth for these patients.
After reviewing thousands of case studies going back 25 years across six countries, generalizable survival data is now available for the first time to estimate how long hip and knee replacements are likely to last.
Geron Corporation today announced the presentation of data from the clinical trial of imetelstat (GRN163L), the company's telomerase inhibitor drug, in combination with paclitaxel and bevacizumab in patients with breast cancer at the 2010 American Society of Clinical Oncology annual meeting in Chicago.
› Verified 5 days ago
| Entity Name | Ohio Anesthesia Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639348113 PECOS PAC ID: 9537222138 Enrollment ID: O20090108000069 |
News Archive
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home, without needing to send a sample to a laboratory for analysis.
SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for point-of-care medicine, today announced the expansion of the SonoAccess™ iPhone® application to include musculoskeletal specialties. SonoAccess is the first iPhone application to provide physicians with a comprehensive multimedia database of ultrasound resource materials.
Patients with recurrent high-grade glioma brain tumors have few effective treatment options and the majority of available therapies do not improve survival. Moffitt Cancer Center will present preliminary results from a phase 1 study testing whether the addition of pembrolizumab to radiation therapy and bevacizumab is safe and can control tumor growth for these patients.
After reviewing thousands of case studies going back 25 years across six countries, generalizable survival data is now available for the first time to estimate how long hip and knee replacements are likely to last.
Geron Corporation today announced the presentation of data from the clinical trial of imetelstat (GRN163L), the company's telomerase inhibitor drug, in combination with paclitaxel and bevacizumab in patients with breast cancer at the 2010 American Society of Clinical Oncology annual meeting in Chicago.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael John Saffian, MD 7757 Auburn Rd, Painesville, OH 44077-9609 Ph: (440) 350-0832 | Dr Michael John Saffian, MD 7007 Powers Blvd, Parma, OH 44129-5437 Ph: (440) 350-0832 |
News Archive
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home, without needing to send a sample to a laboratory for analysis.
SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for point-of-care medicine, today announced the expansion of the SonoAccess™ iPhone® application to include musculoskeletal specialties. SonoAccess is the first iPhone application to provide physicians with a comprehensive multimedia database of ultrasound resource materials.
Patients with recurrent high-grade glioma brain tumors have few effective treatment options and the majority of available therapies do not improve survival. Moffitt Cancer Center will present preliminary results from a phase 1 study testing whether the addition of pembrolizumab to radiation therapy and bevacizumab is safe and can control tumor growth for these patients.
After reviewing thousands of case studies going back 25 years across six countries, generalizable survival data is now available for the first time to estimate how long hip and knee replacements are likely to last.
Geron Corporation today announced the presentation of data from the clinical trial of imetelstat (GRN163L), the company's telomerase inhibitor drug, in combination with paclitaxel and bevacizumab in patients with breast cancer at the 2010 American Society of Clinical Oncology annual meeting in Chicago.
› Verified 5 days ago
Dr. Vincent J Franczek, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7007 Powers Blvd, Parma, OH 44129 Phone: 440-350-0832 Fax: 440-579-0191 | |
Dr. Zoard Alpar Vasarhelyi, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7007 Powers Blvd, Parma, OH 44129 Phone: 440-743-4000 | |
Nelson Delafuente, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 7007 Powers Blvd, Parma, OH 44129 Phone: 440-743-4000 | |
Valeriu Dan Vlasie, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7007 Powers Blvd, Parma, OH 44129 Phone: 440-350-0083 Fax: 440-579-0191 | |
Jonathan H Salewski, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7007 Powers Blvd, Parma, OH 44129 Phone: 440-743-4333 Fax: 440-743-4334 | |
Chirag J Shah, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7007 Powers Blvd, Parma, OH 44129 Phone: 440-350-0832 Fax: 440-579-0191 | |
Dr. Harpreet Singh, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6305 Powers Blvd, Parma, OH 44129 Phone: 440-743-4333 Fax: 440-743-2421 |